학술논문
Higher seroprotection rates (SPR) and higher anti-HBS concentrations in adults age 18-45 immunized with 3-antigen hepatitis B vaccine (3A-HBV) compared to 1-antigen hepatitis B vaccine (1A-HBV): results from the pivotal, double-blind, randomized phase 3 study (CONSTANT).
Document Type
Article
Author
Source
Canadian Liver Journal; Spring2021, Vol. 4 Issue 2, p205-206, 2p
Subject
Language
ISSN
25614444